Abstract |
In this review, we consider recent advances in the discovery and development of antiviral agents for respiratory syncytial virus ( RSV) infections. A background to the various manifestations of human RSV infection and current treatments is provided. The technical, clinical and commercial issues surrounding the development of such antiviral agents are discussed.
|
Authors | Pilar Najarro, Richard Angell, Kenneth Powell |
Journal | Antiviral chemistry & chemotherapy
(Antivir Chem Chemother)
Vol. 22
Issue 4
Pg. 139-50
(Jan 17 2012)
ISSN: 2040-2066 [Electronic] England |
PMID | 22182737
(Publication Type: Journal Article, Review)
|
Copyright | © 2012 International Medical Press |
Chemical References |
|
Topics |
- Antiviral Agents
(therapeutic use)
- Biomedical Research
- Drug Discovery
(economics, methods)
- Drug Industry
(economics)
- Humans
- Models, Biological
- Respiratory Syncytial Virus Infections
(drug therapy, prevention & control)
|